Your browser doesn't support javascript.
loading
Anti-IgE monoclonal antibodies as potential treatment in COVID-19.
Farmani, Ahmad Reza; Mahdavinezhad, Forough; Moslemi, Rohollah; Mehrabi, Zeinab; Noori, Alireza; Kouhestani, Mahsa; Noroozi, Zahra; Ai, Jafar; Rezaei, Nima.
Affiliation
  • Farmani AR; Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahdavinezhad F; Tissue Engineering Department, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran.
  • Moslemi R; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mehrabi Z; Anatomy Department-School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Noori A; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Kouhestani M; Internal Medicine Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Noroozi Z; Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ai J; Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Rezaei N; Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Immunopharmacol Immunotoxicol ; 43(3): 259-264, 2021 Jun.
Article de En | MEDLINE | ID: mdl-34018464
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transduction du signal / Omalizumab / COVID-19 / Traitements médicamenteux de la COVID-19 Limites: Humans Langue: En Journal: Immunopharmacol Immunotoxicol Sujet du journal: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Iran
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transduction du signal / Omalizumab / COVID-19 / Traitements médicamenteux de la COVID-19 Limites: Humans Langue: En Journal: Immunopharmacol Immunotoxicol Sujet du journal: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / TOXICOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Iran